品牌 | 货号 | 包装单位 | 货期 | CAS | 产品名称 | 质量规格 | 单价(¥) | 购买数量 |
---|---|---|---|---|---|---|---|---|
阿拉丁 | A115225-250mg | 250mg | 现货 | 16338-48-0 |
(S)-(-)-2-氨基-4-戊烯酸 (S)-(-)-2-Amino-4-pentenoic ... |
Moligand™, ≥98% |
|
|
阿拉丁 | A115225-1g | 1g | 现货 | 16338-48-0 |
(S)-(-)-2-氨基-4-戊烯酸 (S)-(-)-2-Amino-4-pentenoic ... |
Moligand™, ≥98% |
|
|
阿拉丁 | A115225-5g | 5g | 现货 | 16338-48-0 |
(S)-(-)-2-氨基-4-戊烯酸 (S)-(-)-2-Amino-4-pentenoic ... |
Moligand™, ≥98% |
|
|
阿拉丁 | A115225-25g | 25g | 现货 | 16338-48-0 |
(S)-(-)-2-氨基-4-戊烯酸 (S)-(-)-2-Amino-4-pentenoic ... |
Moligand™, ≥98% |
|
|
阿法埃莎 | C27541-1GR | 1GR | 现货 | 16338-48-0 |
(S)-(-)-2-氨基-4-戊烯酸 (S)-(-)-alpha-Allylglycine, ... |
|
|
|
阿法埃莎 | C27541-250MG | 250MG | 现货 | 16338-48-0 |
(S)-(-)-2-氨基-4-戊烯酸 (S)-(-)-alpha-Allylglycine, ... |
|
|
|
毕得 | BD2863-1g | 1g | 现货 | 16338-48-0 |
(S)-2-氨基-4-戊烯酸 H-Gly(Ally)-OH |
98% |
|
|
毕得 | BD2863-5g | 5g | 现货 | 16338-48-0 |
(S)-2-氨基-4-戊烯酸 H-Gly(Ally)-OH |
98% |
|
|
毕得 | BD2863-10g | 10g | 现货 | 16338-48-0 |
(S)-2-氨基-4-戊烯酸 H-Gly(Ally)-OH |
98% |
|
|
毕得 | BD2863-25g | 25g | 现货 | 16338-48-0 |
(S)-2-氨基-4-戊烯酸 H-Gly(Ally)-OH |
98% |
|
|
毕得 | BD2863-250mg | 250mg | 现货 | 16338-48-0 |
(S)-2-氨基-4-戊烯酸 H-Gly(Ally)-OH |
98% |
|
|
毕得 | BD2863-100g | 100g | 现货 | 16338-48-0 |
(S)-2-氨基-4-戊烯酸 H-Gly(Ally)-OH |
98% |
|
|
Acros | C27541-250MG | 250MG | 现货 | 16338-48-0 |
(S)-(-)-2-氨基-4-戊烯酸 (S)-(-)-alpha-Allylglycine, ... |
|
|
|
Acros | C27541-1g | 1g | 现货 | 16338-48-0 |
(S)-(-)-2-氨基-4-戊烯酸 (S)-(-)-alpha-Allylglycine, ... |
|
|
|
Acros | 275410010 | 1GR | 现货 | 16338-48-0 |
(S)-(-)-2-氨基-4-戊烯酸 (S)-(-)-alpha-Allylglycine, ... |
|
|
|
Acros | 275412500 | 250MG | 现货 | 16338-48-0 |
(S)-(-)-2-氨基-4-戊烯酸 (S)-(-)-alpha-Allylglycine, ... |
|
|
|
乐研 | 1023002-1g | 1g | 现货 | 16338-48-0 |
(S)-(-)-2-氨基-4-戊烯酸 L-Allylglycine |
98% |
|
|
乐研 | 1023002-5g | 5g | 现货 | 16338-48-0 |
(S)-(-)-2-氨基-4-戊烯酸 L-Allylglycine |
98% |
|
|
乐研 | 1023002-10g | 10g | 现货 | 16338-48-0 |
(S)-(-)-2-氨基-4-戊烯酸 L-Allylglycine |
98% |
|
|
乐研 | 1023002-25g | 25g | 现货 | 16338-48-0 |
(S)-(-)-2-氨基-4-戊烯酸 L-Allylglycine |
98% |
|
|